Arrhythmias & EP
Conference Coverage
Real-world data support safety of newer LAA device
More than 18 months after approval, the Watchman FLX left atrial appendage closure device is performing well at 45 days in real-world use.
From the Journals
Handheld ECGs ease AFib screening in the very elderly
But the use of handheld, single-lead electrocardiograms (ECGs) did not increase diagnoses of AFib overall in patients aged 65 and older.
From the Journals
COVID-19 often more severe with congenital heart defects
“Hospitalized patients with heart defects are up to twice as likely to have critical outcomes of COVID-19 illness,” says author of a new study.
From the Journals
Cardiac arrest survival lower in COVID-19 inpatients
“We were surprised by the magnitude of COVID’s impact on the cardiac arrest incidence,” researcher says.
From the Journals
New data explore risk of magnetic interference with implantable devices
Portable electronics embedded with magnets powerful enough to impair CV device functions are proliferating.
From the Journals
AHA targets ‘low-value’ heart care in new scientific statement
Low-value cardiovascular care providing little or no benefit is common, potentially harmful, and costly, and it will take key stakeholders to...
From the Journals
Fewer diabetes complications with NOACs in patients with AFib
Taking non–vitamin K oral anticoagulants is associated with lower mortality and fewer diabetes complications vs. taking warfarin in patients with...
Guidelines
SCAI refines cardiogenic shock classification system
The second iteration of the SCAI cardiogenic shock classification system is based on valuable information gleaned from validation studies and real...
From the Journals
‘Substantial’ CVD risks, burden up to a year after COVID-19
Governments and health systems need to be prepared to deal with the likely significant contribution of the pandemic to a rising burden of...
From the Journals
Seniors face higher risk of other medical conditions after COVID-19
The risk of a new condition being triggered by COVID is more than twice as high in seniors, compared with younger patients, new research suggests...
From the Journals
USPSTF says evidence still lacking for AFib screening in asymptomatic patients
The prevalence of AFib increases in age from less than 0.2% in adults younger than 55 years to about 10% in those 85 years or older.